.png){kind=icon}
.png){kind=icon}
Return
Induced Pluripotent Stem Cell-Derived Cardiomyocyte Therapy for Ischemic Heart Failure
.png){kind=icon}
PRE
AI
C
DOI：10.1111/aor.70127.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Induced pluripotent stem cell-derived cardiomyocyte therapy represents an important milestone in cardiac regenerative therapy for ischemic heart failure. Early human experience with epicardial cell-sheet implantation demonstrated procedural feasibility and short-term safety, with signs of improved left ventricular contractility and myocardial perfusion. Although clinical experience remains limited, these findings suggest that cardiomyocyte-based regenerative therapy may eventually complement established therapies for advanced heart failure.
Journal
A
IF:
2.3
Papers:
98
Citations:
0
Organization
Cited Papers